Use of Pre- and Intensified Postprocedural Physiotherapy in Patients with Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Study (the 4P-TAVR Study)
Table 1
Baseline parameters.
All patients (n = 108)
Training group (n = 58)
Control group (n = 50)
Age (years)
82.0 ± 5.5
82.2 ± 5.8
81.7 ± 5.0
Female gender (n (%))
55 (50.9)
31 (53.4)
24 (48)
BMI (kg/m2)
26.8 ± 4.6
26.3 ± 4.7
27.4 ± 4.5
STS-PROM (%)
7.8 ± 6.1
8.5 ± 7.0
7.0 ± 4.8
Logistic EuroSCORE (%)
21.1 ± 14.3
21.5 ± 14.1
20.7 ± 14.7
NYHA class
3.1 ± 0.5
3.1 ± 0.5
3.1 ± 0.4
NYHA class >2 (n (%))
100 (93)
53 (91)
47 (94)
COLD (n (%))
23 (21)
16 (28)
7 (14)
CAD (n (%))
70 (64.8)
34 (58.6)
36 (72)
AF (n (%))
46 (42.6)
26 (44.8)
20 (40)
LVEF (%)
54.0 ± 12.9
53.5 ± 11.9
54.6 ± 14.1
Pressure mean gradient (mmHg)
40.7 ± 14.8
40.9 ± 15.7
40.4 ± 13.6
MR ≥ II° (n (%))
6 (6)
2 (3)
4 (8)
Pulmonary artery pressure (mmHg)
36.2 ± 18.9
35.6 ± 18.1
37.0 ± 20.0
Creatinine (mg/dl)
1.48 ± 0.82
1.58 ± 1.13
1.31 ± 0.50
NT-pro BNP (ng/ml)
4725 ± 5760
4507 ± 5182
4996 ± 6455
Baseline six-minute walk test (m)
222.1 ± 115.4
221.4 ± 109.1
223.1 ± 124.5
Procedure duration (min)
74.2 ± 34.9
71.2 ± 29.7
77.9 ± 40.5
Amount of contrast media (ml)
148.2 ± 44.8
145.3 ± 40.4
151.7 ± 49.8
BMI, body mass index; STS-PROM, Society of thoracic surgeons predicted probability of mortality score; COLD, chronic obstructive lung disease; CAD, coronary artery disease; LVEF, left ventricular ejection fraction; AF, atrial fibrillation; MR, mitral regurgitation; there were no significant differences between the groups; therefore, values were omitted in the baseline characteristics due to the randomized study design.
